General form of registration statement for all companies including face-amount certificate companies

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)

v3.20.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
Convertible Series F Preferred Stock
Convertible Series D Preferred Stock
Redeemable Convertible Series B Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2017 $ 1,777,781 $ 169,447 $ 822,201 $ 33,623 $ 10,427,742 $ (14,030,871) $ (3,569,506)
Balance (in shares) at Dec. 31, 2017 2,000 200 2,834 33,622,829      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock based compensation expense         674,961   674,961
Common stock issued for services       $ 3,143 (3,143)    
Common stock issued for services (in shares)       3,143,501      
Issuance of common stock net of issuance costs of $16,900       $ 32,500 (49,400)   (16,900)
Issuance of common stock net of issuance costs of $16,900 (in shares)       32,500,000      
Conversion of Series B Preferred Stock and conversion liability into common stock at $0.10 and $0.001 per share     $ (822,201) $ 28,385 800,530   828,915
Conversion of Series B Preferred Stock and conversion liability into common stock at $0.10 and $0.001 per share (in shares)     (2,834) 28,385,000      
Conversion of Series D Preferred Stock to common stock at $0.10 per share   $ (169,447)   $ 2,000 167,447   169,447
Conversion of Series D Preferred Stock to common stock at $0.10 per share (in shares)   (200)   2,000,000      
Conversion of Series F Preferred Stock to common stock at $0.10 per share $ (1,777,781)     $ 20,000 1,757,781   1,777,781
Conversion of Series F Preferred Stock to common stock at $0.10 per share (in shares) (2,000)     20,000,000      
Conversion of secured convertible promissory note - related party and accrued interest       $ 9,038 1,714,522   1,723,560
Conversion of secured convertible promissory note - related party and accrued interest (in shares)       9,037,667      
Warrants issued in connection with convertible multi-draw credit agreement, related party         315,080   315,080
Beneficial conversion feature in connection with convertible multi-draw credit agreement - related party         90,080   90,080
Series B warrant exercises       $ 5,219 1,633,347   1,638,566
Series B warrant exercises (in shares)       5,218,750      
Net loss for the year           (19,194,236) (19,194,236)
Balance at Dec. 31, 2018       $ 133,908 17,528,947 (33,225,107) (15,562,252)
Balance (in shares) at Dec. 31, 2018       133,907,747      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock based compensation expense         171,493   171,493
Warrants issued in connection with convertible multi-draw credit agreement, related party         716,110   716,110
Beneficial conversion feature in connection with convertible multi-draw credit agreement - related party         1,584,850   1,584,850
Net loss for the year           (14,774,392) (14,774,392)
Balance at Mar. 31, 2019       $ 133,908 20,001,400 (47,999,499) (27,864,191)
Balance (in shares) at Mar. 31, 2019       133,907,747      
Balance at Dec. 31, 2018       $ 133,908 17,528,947 (33,225,107) (15,562,252)
Balance (in shares) at Dec. 31, 2018       133,907,747      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock based compensation expense         680,455   680,455
Issuance of common stock and warrants, net of issuance costs of $80,628       $ 8,000 1,911,372   1,919,372
Issuance of common stock and warrants, net of issuance costs of $80,628 (in shares)       8,000,000      
Warrants issued in connection with convertible multi-draw credit agreement, related party         716,110   716,110
Beneficial conversion feature in connection with convertible multi-draw credit agreement - related party         1,584,850   1,584,850
Series B warrant exercises       $ 187 144,188   144,375
Series B warrant exercises (in shares)       187,500      
Exercise of Emerald financing warrants       $ 40,800 9,972,523   10,013,323
Exercise of Emerald financing warrants (in shares)       40,800,000      
Net loss for the year           1,051,825 1,051,825
Balance at Dec. 31, 2019       $ 182,895 32,538,445 (32,173,282) 548,058
Balance (in shares) at Dec. 31, 2019       182,895,247      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock based compensation expense         64,142   64,142
Series B warrant exercises       $ 313 26,250   26,563
Series B warrant exercises (in shares)       312,500      
Net loss for the year           (2,341,660) (2,341,660)
Balance at Mar. 31, 2020       $ 183,208 $ 32,628,837 $ (34,514,942) $ (1,702,897)
Balance (in shares) at Mar. 31, 2020       183,207,747